Big Pharma providing ‘Useless and sometimes harmful drugs’

The Queen’s former doctor, also former-president of the Royal College of Physicians Sir Richard Thompson is part of a group of six eminent doctors warning about the negative influence of pharmaceutical companies in the public health arena. The group has called for an urgent and independent public enquiry into drugs firms’ ‘murky’ practices by Parliament’s Public Accounts Committee.

One of the group’s other experts, NHS cardiologist Dr Aseem Malhotra, two years ago (along with 11 other cardiologists), told the UK Prime Minister to adopt the colourful Mediterranean Diet as a way of ‘preventing all the chronic illnesses that beset the Western World’, instead of ‘popping pills’. Then, one of the targets was statins.

The new group claims that too often patients are given useless and sometimes harmful drugs that they simply do not need. They claim public funding is often allocated to medical research because it is likely to be profitable, not because it will be beneficial for patients.

Crucially, whilst they accuse the NHS of failing to stand up to Big Pharma, they argue that the latter are developing medicines they can profit from, rather than those, which are likely to be the most beneficial to patients.

But the strongest words were left to last. Thompson and his colleagues accuse the NHS of ‘over-treating’ its patients, arguing that the side-effects of too much Big Pharma medicine is leading to countless deaths’.

Examples of the over-claims and money wasting include half a billion pounds on Tamiflu that was neither needed nor worked, and statins, where the original clinical trial data has never ever been published.

Only recently statins have been shown to double the risk of diabetes.

, , , , , , , , , ,

Aspirin and cancer trial doomed to failure?

Hailing it as the “world’s largest clinical trial to investigate whether taking aspirin every day stops the recurrence of some of the most common cancers”, the NHS and Cancer Research UK are taking more than 11,000 patients from 100 centres across the UK.

The study will run for 12 years and involves different groups taking different doses of aspirin

Somewhat bizarrely, the dosages will be 100 and/or 300 mgs.

What is odd about this is that the original discovery of the aspirin effect, John Vane (who won a Nobel Prize and a Knighthood for his efforts, showed clearly that the dose need be no more than 75 mgs. This research was confirmed by the Mayo clinic who felt the benefit came from a small dose (81 mgs).

Further large studies from Oxford University and The Radcliffe Hospital, and from the Francis Crick Institute in London have confirmed that aspirin can reduce inflammation throughout the body (a precursor to cancer), can greatly reduce cancer spread and increase survival times, and can even prevent the cancer from hiding from the immune system.

Prof Ruth Langley, the chief investigator at the Medical Research Council’s clinical trials unit at University College London, said: “There has been some interesting research suggesting that aspirin could delay or stop early-stage cancers coming back, but there has been no randomised trial to give clear proof. This trial aims to answer this question once and for all.

“If we find that aspirin does stop these cancers returning, it could change future treatment – providing a cheap and simple way to help stop cancer coming back and helping more people survive.

“But, unless you are on the trial, it’s important not to start taking aspirin until we have the full results, as aspirin isn’t suitable for everyone, and it can have serious side-effects.”

And this is a real problem. CANCERactive has consistently informed of the increasing research on the benefits of aspirin, but in the small dose size. Even then we have known patients develop serious side-effects like stomach ulcers.

We are extremely concerned that patients taking the higher 300 mgs dose especially will show a greatly increased risk of stomach ulcers, with the whole trial having to be curtailed.

We predict high levels of side-effects and publicity saying aspirin is dangerous, when at the smaller dosage it has already-proven significant benefits.

, , , , , , , , , , , , ,

2015 Flu Vaccine “USELESS”

According to various National newspapers in the UK in the last 24 hours, the current flu vaccine doesn’t work in about 97% of cases.

And with reports that the number of deaths this winter will be the highest for 15 years, this winter’s flu jab is declared “useless” in several newspapers.

Variously, the Daily Telegraph describes how the dominant strain of the virus currently in circulation is a “different mutation” from the type expected; the Daily Mail says the NHS spends £100m a year on its flu vaccination programme, targeting “at risk” groups and quotes Katherine Murphy, from the Patients’ Association, saying: “It beggars belief that health officials weren’t aware just how badly the vaccine was working a long time ago”.

And the Independent says that to make sufficient quantities of the vaccine the WHO plays ‘guess the strain that’s coming’ 6 months in advance. And mutation can easily take place over that period.

Apparently, even in a good year, the vaccine only works in about half of those vaccinated. In 2015 health officials have been describing serious outbreaks of flu in care homes and a surge in UK hospital admissions.

, , , , , ,